|
Cephudder ointment
Cephapirin
|
Suspension for Injection
|
Zambia
|
331/708VD
|
Registered/Compliant
|
|
Covexin 10 Vaccine
C. chauvoei 90 % Units,C. haemolyticum 10 Units,C. novyi type B toxoid 3.5 Units,C. perfringens type A toxoid 0.5 Units,C. perfringens type B toxoid 10 IU,C. perfringens type C toxoid 10 IU,C. perfringens type D toxoid 5 IU,C. septicum toxoid 2.5 IU,C. sordellii toxoid 1 unit,C. tetani toxoid 2.5 IU
|
Suspension for Injection
0.5 Units,1 unit,10 IU,10 Units,2.5 IU,3.5 Units,5 IU,90 % Units
|
Zambia
|
331/713VD
|
Registered/Compliant
|
|
Decatix
Deltamethrin 5% m/v ml
|
Concentrate for Topical Administration
5% m/v ml
|
Zambia
|
ZAMRA-VM-26-27
|
Registered/Compliant
|
|
Exit Topical Liquid
Deltamethrin + Piperonyl Butoxide
|
Solution for Topical Use
|
Zambia
|
335/707V
|
Registered/Compliant
|
|
Lumpyvax
Attenuated Lumpy skin disease virus (SIS Neethling-type), at least 104.0TCID50 1x 10^4 TCID50 – 5 x 10^5 TCID50 of freeze-dried, CCID50% per dose
|
Lyophilisate for suspension
1x 10^4 TCID50 – 5 x 10^5 TCID50 of freeze-dried, CCID50% per dose
|
Zambia
|
ZAMRA-VM-26-187
|
Registered/Compliant
|
|
Nobilis Gumboro 228E
Infectious Bursal Disease Virus
|
Lyophilized for suspension
Live Gumboro disease virus strain 228E, at least 2 ml
|
Zambia
|
331/715V
|
Registered/Compliant
|
|
Nobilis IB 4-91 Vaccine
Live attenuated infectious bronchitis virus strain 4-91 >/= 3.6 log10 EID50* per dose Units
|
Lyophilized for suspension
>/= 3.6 log10 EID50* per dose Units
|
Zambia
|
ZAMRA-HM-26-253
|
Registered/Compliant
|
|
Nobilis IB+ND+EDS
Inactivated EDS ’76 virus Inducing’ ≥ 6,5 log2 HI units per dose unit,Inactivated IB virus Massachusetts type Inducing’ ≥ 6,0 log2 HI units per dose unit,Inactivated ND virus Inducing’ ≥ 4 log2 HI units per 1 50 dose or conta unit
|
Emulsion for injection
Inducing’ ≥ 4 log2 HI units per 1 50 dose or conta unit,Inducing’ ≥ 6,0 log2 HI units per dose unit,Inducing’ ≥ 6,5 log2 HI units per dose unit
|
Zambia
|
331/707V
|
Registered/Compliant
|
|
Nobilis Rismavac
Live Marek's Disease virus strain CVI988 at least 3.0 log10 TCID50 per bird dose doses
|
Suspension for intramuscular injection
at least 3.0 log10 TCID50 per bird dose doses
|
Zambia
|
331/725V
|
Registered/Compliant
|
|
Nobilis® MG Inac
M. gallisepticum , strain S6/85, bacterial concentrate inactivated by thiomersal Greater than or equal to 0.23 OU
|
Injectable emulsion
Greater than or equal to 0.23 OU
|
Zambia
|
331/721V
|
Registered/Compliant
|
|
Nobilis® ND C2
Live attenuated New Castle Virus (NDV) strain C2 At least 5.7 Log10 EID50 per dose microgram
|
Lyophilisate for suspension
At least 5.7 Log10 EID50 per dose microgram
|
Zambia
|
331/722V
|
Registered/Compliant
|
|
Nobilis® Reo IB+G+ND
IBV M41 Inducing greater than or equal to 6.0 log2 HI unit microgram,NDV Inducing greater than or equal to 4.0 log2 HI unit microgram
|
Emulsion for injection
Inducing greater than or equal to 4.0 log2 HI unit microgram,Inducing greater than or equal to 6.0 log2 HI unit microgram
|
Zambia
|
331/719V
|
Registered/Compliant
|
|
Nobilis®Reo Live (2177)
Reovirus strain 2177 At least 3.1 log10 TCID50 per dose microgram
|
Lyophilisate for suspension
At least 3.1 log10 TCID50 per dose microgram
|
Zambia
|
331/709V
|
Registered/Compliant
|
|
Paracox
E. brunetti HP 100 oocysts per doses,E. maxima CP 200 oocysts per doses,E. maxima MFP 100 oocysts per doses,E. mitis HP 1000 oocysts per doses,E. necatrix HP 500 oocysts per doses,E. praecox HP 100 oocysts per doses,E. tenella HP 500 oocysts per doses,Eimeria acervulina HP 500 oocysts per doses
|
Suspension for Oral Use
100 oocysts per doses,1000 oocysts per doses,200 oocysts per doses,500 oocysts per doses
|
Zambia
|
331/711VD
|
Registered/Compliant
|
|
Receptal
Buserelin acetate 0.0042mg per ml
|
Solution for Injection
|
Zambia
|
331/727V
|
Registered/Compliant
|
|
Salix 5%
Furosemide 50 mg/ml
|
Solution for Injection
50 mg/ml
|
Zambia
|
331/728V
|
Registered/Compliant
|